Home › Companies › ROCKET PHARMACEUTICALS INC. › 2023-2024

ROCKET PHARMACEUTICALS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and ROCKET PHARMACEUTICALS INC.’s Form 8-K, filed 2024-06-20 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 16Reported items
  • 239Asset managers
  • 3,536Fund votes
  • 2024-06-13Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ROCKET PHARMACEUTICALS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ROCKET PHARMACEUTICALS INC.

These tallies are ROCKET PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-20 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ROCKET PHARMACEUTICALS INC. — official shareholder meeting results, meeting held 2024-06-13
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Elisabeth Björk, M.D., Ph.D. 67,603,904---- 4,348,3297,857,537 Majority: yes
Elect Director: Carsten Boess 71,383,452---- 568,7817,857,537 Majority: yes
Elect Director: Pedro Granadillo 51,458,742---- 20,493,4917,857,537 Majority: yes
Elect Director: Gotham Makker, M.D. 71,537,718---- 414,5157,857,537 Majority: yes
Elect Director: Fady Malik, M.D., Ph.D. 71,706,448---- 245,7857,857,537 Majority: yes
Elect Director: Gaurav Shah, M.D. 71,555,239---- 396,9947,857,537 Majority: yes
Elect Director: David P. Southwell 71,650,603---- 301,6307,857,537 Majority: yes
Elect Director: Roderick Wong, M.D. 71,278,861---- 673,3727,857,537 Majority: yes
Elect Director: R. Keith Woods 69,222,478---- 2,729,7557,857,537 Majority: yes
Elect Director: Naveen Yalamanchi, M.D. 63,231,665---- 8,720,5687,857,537 Majority: yes

Source: ROCKET PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-06-20 — read the filing on EDGAR.

How asset managers voted at the ROCKET PHARMACEUTICALS INC. 2023-2024 meeting

Each item below shows how the 239 asset managers that disclosed a ROCKET PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ROCKET PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS.

SECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

99.2% fund support · no official result

FOR 99.2%

The 228 asset managers below cast 99.2% of the shares they voted on this item FOR (87,820,539 for, 673,230 against).

FOR: 87,820,539 (99.2%)AGAINST: 673,230 (0.8%)ABSTAIN: 264 (0.0%)
Largest asset managers voting on “APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RTW INVESTMENTS, LP14,343,5710 00For
Vanguard10,287,5540 00For
Wellington8,071,2720 00For
Putnam6,728,3560 00For
State Street6,539,4550 00For
T. Rowe Price5,347,2970 00For
BlackRock4,318,7740 00For
WESTFIELD CAPITAL MANAGEMENT CO LP2,734,7550 00For
Fidelity2,593,0470 00For
MAVERICK CAPITAL LTD2,049,0670 00For
Janus Henderson2,011,8150 00For
GEODE CAPITAL MANAGEMENT, LLC1,499,6720 00For
Boxer Capital, LLC1,466,0510 00For
PICTET ASSET MANAGEMENT SA1,189,8150 00For
JANUS INVESTMENT FUND1,166,5230 00For
Logos Global Management LP1,150,0000 00For
FRANKLIN ADVISERS INC1,115,8820 00For
Charles Schwab1,066,1660 00For
BAMCO INC /NY/951,5240 00For
HARBOR FUNDS914,9510 00For
Dimensional904,9920 00For
Avidity Partners Management LP850,0200 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Russell Investments586,3430 00For

Showing the 25 largest of 228 asset managers. See all 228 in the interactive database.

2. Election of Directors: Carsten Boess

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 71,383,452WITHHELD: 568,781

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Carsten Boess”): 71,383,452 for, 568,781 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 79% for, 0.7% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (35,390,102 for, 0 against).

FOR 99.9%
FOR: 35,390,102 (100.0%)ABSTAIN: 1,892 (0.0%)
Largest asset managers voting on “Election of Directors: Carsten Boess” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,692,7370 2840For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

3. Election of Directors: David P. Southwell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 71,650,603WITHHELD: 301,630

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David P. Southwell”): 71,650,603 for, 301,630 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 79% for, 0.4% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (35,389,998 for, 0 against).

FOR 99.9%
FOR: 35,389,998 (100.0%)ABSTAIN: 1,996 (0.0%)
Largest asset managers voting on “Election of Directors: David P. Southwell” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,692,6330 3880For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

4. Election of Directors: Fady Malik, M.D., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 71,706,448WITHHELD: 245,785

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Fady Malik, M.D., Ph.D.”): 71,706,448 for, 245,785 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 79% for, 0.3% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (35,390,102 for, 0 against).

FOR 99.9%
FOR: 35,390,102 (100.0%)ABSTAIN: 1,892 (0.0%)
Largest asset managers voting on “Election of Directors: Fady Malik, M.D., Ph.D.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,692,7370 2840For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

5. Election of Directors: Gaurav Shah, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 71,555,239WITHHELD: 396,994

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gaurav Shah, M.D.”): 71,555,239 for, 396,994 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 79% for, 0.5% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (35,345,998 for, 0 against).

FOR 99.8%
FOR: 35,345,998 (99.9%)ABSTAIN: 45,996 (0.1%)
Largest asset managers voting on “Election of Directors: Gaurav Shah, M.D.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,692,6330 3880For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

6. Election of Directors: Gotham Makker, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 71,537,718WITHHELD: 414,515

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gotham Makker, M.D.”): 71,537,718 for, 414,515 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 79% for, 0.5% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (35,345,998 for, 0 against).

FOR 99.8%
FOR: 35,345,998 (99.9%)ABSTAIN: 45,996 (0.1%)
Largest asset managers voting on “Election of Directors: Gotham Makker, M.D.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,692,6330 3880For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

7. Election of Directors: Naveen Yalamanchi, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 63,231,665WITHHELD: 8,720,568

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Naveen Yalamanchi, M.D.”): 63,231,665 for, 8,720,568 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 70% for, 10% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (30,868,921 for, 0 against).

FOR 87%13%
FOR: 30,868,921 (87.2%)ABSTAIN: 4,523,073 (12.8%)
Largest asset managers voting on “Election of Directors: Naveen Yalamanchi, M.D.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock00 2,919,5490Abstain
State Street2,692,7370 2840For
T. Rowe Price2,358,6490 00For
Fidelity1,982,9220 31,7730For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab00 533,0830Abstain
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES00 345,3460Abstain
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable79,6990 96,8770Abstain
Global X00 164,7220Abstain
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

8. Election of Directors: Pedro Granadillo

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%WITHHELD 28%
FOR: 51,458,742WITHHELD: 20,493,491

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Pedro Granadillo”): 51,458,742 for, 20,493,491 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 57% for, 23% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 99.9% of the shares they voted on this item FOR (26,568,323 for, 73 against).

FOR 75%ABSTAIN 25%
FOR: 26,568,323 (75.1%)AGAINST: 73 (0.0%)ABSTAIN: 8,823,598 (24.9%)
Largest asset managers voting on “Election of Directors: Pedro Granadillo” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,8450 2,690,1760Abstain
T. Rowe Price2,358,6490 00For
Fidelity1,438,5800 576,1150For
JANUS INVESTMENT FUND703,5510 462,9720For
HARBOR FUNDS49,2960 865,6550Abstain
Dimensional00 777,6920Abstain
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 690,2700Abstain
Charles Schwab00 533,0830Abstain
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES00 345,3460Abstain
BARON SELECT FUNDS00 261,2540Abstain
John Hancock164,8230 23,4120For
Jackson National172,2000 14,5570For
Direxion Shares ETF Trust00 177,8050Abstain
Equitable110,2860 66,2900For
Global X00 164,7220Abstain
Mercer Funds00 159,1110Abstain
TIAA00 158,2080Abstain
Victory Capital1,9640 129,3690Abstain
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

9. Election of Directors: R. Keith Woods

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 69,222,478WITHHELD: 2,729,755

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: R. Keith Woods”): 69,222,478 for, 2,729,755 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 76% for, 3% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (28,149,912 for, 0 against).

FOR 80%ABSTAIN 20%
FOR: 28,149,912 (79.5%)ABSTAIN: 7,242,082 (20.5%)
Largest asset managers voting on “Election of Directors: R. Keith Woods” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam00 5,976,8710Abstain
BlackRock2,919,5490 00For
State Street2,693,0210 00For
T. Rowe Price2,358,6490 00For
Fidelity1,438,5800 576,1150For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab00 533,0830Abstain
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

10. Election of Directors: Roderick Wong, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 71,278,861WITHHELD: 673,372

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Roderick Wong, M.D.”): 71,278,861 for, 673,372 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 79% for, 0.8% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (35,306,066 for, 0 against).

FOR 99.7%
FOR: 35,306,066 (99.8%)ABSTAIN: 85,928 (0.2%)
Largest asset managers voting on “Election of Directors: Roderick Wong, M.D.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,692,6330 3880For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

11. Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 82 asset managers below cast 99.9% of the shares they voted on this item FOR (35,390,010 for, 439 against).

FOR: 35,390,010 (100.0%)AGAINST: 439 (0.0%)
Largest asset managers voting on “Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting f” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,692,582439 00For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

12. Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock.

CAPITAL STRUCTURE

Combines 3 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 81 asset managers below cast 99.8% of the shares they voted on this item FOR (35,332,419 for, 44,000 against).

FOR: 35,332,419 (99.9%)AGAINST: 44,000 (0.1%)
Largest asset managers voting on “Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increas” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street2,693,0210 00For
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

13. Election of Directors: Elisabeth Bjork, M.D., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 67,603,904WITHHELD: 4,348,329

ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Elisabeth Björk, M.D., Ph.D.”): 67,603,904 for, 4,348,329 withheld, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,646,590 outstanding shares: 75% for, 5% withheld (79% of the company cast a for/withheld vote).

The 79 asset managers below cast 100% of the shares they voted on this item FOR (32,618,869 for, 0 against).

FOR 92%8%
FOR: 32,618,869 (92.5%)ABSTAIN: 2,663,799 (7.5%)
Largest asset managers voting on “Election of Directors: Elisabeth Bjork, M.D., Ph.D.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,108,2130 00For
Putnam5,976,8710 00For
BlackRock2,919,5490 00For
State Street55,7240 2,637,2970Abstain
T. Rowe Price2,358,6490 00For
Fidelity2,014,6950 00For
JANUS INVESTMENT FUND1,166,5230 00For
HARBOR FUNDS914,9510 00For
Dimensional777,6920 00For
Hartford738,3080 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)690,2700 00For
Charles Schwab533,0830 00For
MUTUAL FUND SERIES TRUST490,7320 00For
Russell Investments451,1460 00For
FRANKLIN STRATEGIC SERIES345,3460 00For
BARON SELECT FUNDS261,2540 00For
John Hancock188,2350 00For
Jackson National186,7570 00For
Direxion Shares ETF Trust177,8050 00For
Equitable176,5760 00For
Global X164,7220 00For
Mercer Funds159,1110 00For
TIAA158,2080 00For
Victory Capital131,3330 00For
Northwestern Mutual127,1420 00For

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

14. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

79% fund support · no official result

FOR 79%AGAINST 21%

The 6 asset managers below cast 79% of the shares they voted on this item FOR (849,602 for, 224,439 against).

FOR: 849,602 (79.1%)AGAINST: 224,439 (20.9%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JPMorgan597,0550 00For
NORDEA INVESTMENT MANAGEMENT AB0154,070 00Against
EFG Asset Management (North America) Corp.151,0020 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.100,0000 00For
Desjardins Global Asset Management Inc.070,369 00Against
Virtus1,5450 00For

15. Election of Directors: Elisabeth Bj?rk, M.D., Ph.D.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 56%ABSTAIN 44%

The 6 asset managers below cast 100% of the shares they voted on this item FOR (61,126 for, 0 against).

FOR: 61,126 (55.9%)ABSTAIN: 48,200 (44.1%)
Largest asset managers voting on “Election of Directors: Elisabeth Bj?rk, M.D., Ph.D.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Lincoln Financial6,0080 48,2000Abstain
Brighthouse45,2970 00For
Blackstone Alternative Investment Funds3,6000 00For
SA FUNDS INVESTMENT TRUST3,5760 00For
CLEARWATER INVESTMENT TRUST2,5720 00For
Keel Point, LLC730 00For

16. To consider and act upon a non-binding, advisory vote on the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,430,510 for, 0 against).

FOR: 1,430,510 (100.0%)
Largest asset managers voting on “To consider and act upon a non-binding, advisory vote on the compensation of our named executive officers.” at ROCKET PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Novo Holdings A/S1,100,0000 00For
ACUTA CAPITAL PARTNERS, LLC330,5100 00For

Largest ROCKET PHARMACEUTICALS INC. shareholders voting in 2023-2024

Ranked by the number of ROCKET PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 90,646,590 shares outstanding at the time of that meeting.

Top ROCKET PHARMACEUTICALS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1RTW INVESTMENTS, LP 15.82%
2Vanguard 11.35%
3Wellington 8.90%
4Putnam 7.42%
5State Street 7.21%
6T. Rowe Price 5.90%
7BlackRock 4.76%
8WESTFIELD CAPITAL MANAGEMENT CO LP 3.02%
9Fidelity 2.86%
10MAVERICK CAPITAL LTD 2.26%

Reported ROCKET PHARMACEUTICALS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ROCKET PHARMACEUTICALS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Roderick Wong, M.D. 20.27% DEF14A
RTW Investments, LP 20.07% DEF14A
Wellington Management 10.10% 13F
BlackRock 7.85% 13F
Vanguard Group 7.60% 13F
State Street 4.63% 13F
Morgan Stanley 4.02% 13F
T. Rowe Price 3.25% 13F
Gaurav Shah, M.D. 3.11% DEF14A
Citadel Advisors 2.79% 13F

Percentages above are of 90,646,590 shares outstanding, as reported by ROCKET PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROCKET PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ROCKET PHARMACEUTICALS INC.'s shareholder meeting held 2024-06-13, in the 2023-2024 proxy season, 239 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,536 separate fund positions. Their filings are grouped here into 16 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ROCKET PHARMACEUTICALS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING… — the reporting funds cast 99.2% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

ROCKET PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.